Skip to main content

Table 1 Baseline characteristics of the study population

From: The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population

Variables

Number (%)

Gender

 

Male

31 (27.2)

Female

83 (72.8)

Total

114 (100)

Age group (years)

 

15 – 24

2 (1.7)

25 – 34

23 (20.2)

35+

89 (78.1)

Total

114 (100)

CD4 count

 

<350

42 (36.8)

350 – 499

32 (28.1)

500+

40 (35.1)

Total

114 (100)

Duration of ART*(years)

 

<2

38 (34.2)

2 – 4

30 (27.0)

5+

43 (38.7)

Total

111 (100)

NRTI** regimen

 

AZT-based

75 (65.8)

D4T-based

4 (3.5)

TDF-based

35 (30.7)

Total

114 (100)

NNRTI** regimen

 

EFV-based

54 (47.4)

NVP-based

60 (52.6)

Total

114 (100)

Smoking

 

No

106 (94.6)

Yes

6 (5.4)

Total

112 (100)

Alcohol intake

 

No

63 (56.2)

Yes

49 (43.5)

Total

112 (100)

Heart condition

 

No

104 (93.7)

Yes

7 (6.3)

Total

111 (100)

Metabolic condition

 

No

102 (91.9)

Yes

9 (8.1)

Total

111 (100)

Special diet

 

No

101 (91.0)

Yes

10 (9.0)

Total

111 (100)

ART interruption

 

No

107 (95.5)

Yes

5 (4.5)

Total

112 (100)

  1. * ART = antiretroviral therapy, **NRTI = nucleotide reverse transcriptase inhibitors, *** NNRTI = non-nucleotide reverse transcriptase inhibitor, AZT = zidovudine, 3TC = lamivudine, TDF = tenofovir, D4T = stavudine, EFV = efavirenz, NVP = nevirapine.